Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
RESEARCH TOOLSreports
Immix Biopharma, Inc. (IMMX) Financial Statements
96 Followers
Immix Biopharma, Inc. Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -4.34M | $ -3.59M | $ -2.49M | $ -3.79M | $ -1.53M |
| EBITDA | $ -4.34M | $ -3.59M | $ -2.49M | $ -3.79M | $ -1.53M |
| Net Income Common Stockholders | $ -4.28M | $ -3.58M | $ 2.57M | $ -3.80M | $ -1.54M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 19.58M | $ 12.65M | $ 11.46M | $ 13.44M | $ 16.92M |
| Total Assets | $ 22.47M | $ 15.57M | $ 13.21M | $ 14.91M | $ 17.40M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -19.58M | $ -12.65M | $ -11.46M | $ -13.44M | $ -16.92M |
| Total Liabilities | $ 2.83M | $ 2.40M | $ 1.47M | $ 1.75M | $ 646.46K |
| Stockholders Equity | $ 19.77M | $ 13.23M | $ 11.77M | $ 13.16M | $ 16.75M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -3.13M | $ -3.52M | $ -2.09M | $ -3.90M | $ -1.46M |
| Operating Cash Flow | $ -3.09M | $ -3.52M | $ -2.09M | $ -3.90M | $ -1.46M |
| Investing Cash Flow | $ -38.91K | - | - | - | $ 0.00 |
| Financing Cash Flow | $ 10.07M | $ 4.69M | $ 118.92K | $ 424.28K | $ 0.00 |
Immix Biopharma, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.